Express Scripts Holding Co (ESRX)

ESRX (NASDAQ:Health Services) EQUITY
$75.55
pos +0.58
+0.77%
Today's Range: 74.45 - 75.64 | ESRX Avg Daily Volume: 4,409,900
Last Update: 05/31/16 - 4:14 PM EDT
Volume: 4,509,357
YTD Performance: -14.23%
Open: $74.61
Previous Close: $74.97
52 Week Range: $65.55 - $94.61
Oustanding Shares: 632,536,000
Market Cap: 47,421,223,920
6-Month Chart
TheStreet Ratings Grade for ESRX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 7 8
Moderate Buy 0 0 0 0
Hold 8 8 9 8
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.18 2.18 2.29 2.18
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 19.89
Price Earnings Comparisons:
ESRX Sector Avg. S&P 500
19.89 21.10 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
5.10% -16.45% 19.61%
GROWTH 12 Mo 3 Yr CAGR
Revenue 0.90 0.10 0.03
Net Income 22.80 0.80 0.22
EPS 34.80 1.00 0.26
Earnings for ESRX:
EBITDA 6.70B
Revenue 101.75B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $1.58 $1.74 $6.36 $6.84
Number of Analysts 11 10 12 12
High Estimate $1.59 $1.87 $6.40 $7.22
Low Estimate $1.56 $1.69 $6.33 $6.55
Prior Year $1.44 $1.45 $5.53 $6.36
Growth Rate (Year over Year) 9.41% 19.79% 15.01% 7.52%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Prices stabilized and have rallied smartly in the past few weeks.
Selecting a good company is important; getting in at a nice price makes things even better.
Bearish
Feb 22, 2016 | 7:34 AM EST
ESRX was downgraded from Hold to Sell, Credit Suisse said. $61 price target. Troubles with Anthem will likely have a material earnings ...
Don't be surprised if Anthem's threat to take its business elsewhere results in a compromise.
Bearish
Jan 19, 2016 | 7:46 AM EST
ESRX was downgraded to Market Perform, Leerink Partners said. $80 price target. Company is losing market share to CVS.
A weekly close below $80 will complete a top formation and likely precipitate further declines.
Don't catch falling knives, and don't ignore dividends.
A beginning-of-December look back at our portfolio through the lens of capital preservation.
A surge over $142 would generate more price gains.

Columnist Conversations

Agribusiness Bunge (BG) showed some bullish option buying last week. The stock gained another $1.28 per share,...
The Fed has been talkative lately about the 'strength' in the economy with a 2% rate of growth. Certainly tha...
Market flat as we hit the noon hour. Oil tries once again to scale the $50 level. Biotech goes for three wee...
I would think he sees the boatload of cash coming to AGN if/when they close the TEVA deal for their generics. ...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.